Thurston, Springer, Miller, Herd & Titak, Inc. Organon & Co. Transaction History

Thurston, Springer, Miller, Herd & Titak, Inc.

$46.2 Million
Q3 2025

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	BUY	$8.04 - $14.72 $48 - $88	6 Added 13.33%	51 $0
Q1 2025 Apr 10, 2025	SELL	$14.29 - $16.41 $42 - $49	-3 Reduced 6.25%	45 $0
Q4 2024 Jan 14, 2025	SELL	$14.44 - $18.83 $14 - $18	-1 Reduced 2.04%	48 $0
Q2 2024 Jul 05, 2024	BUY	$17.45 - $21.96 $855 - $1,076	49 New	49 $1,000

Others Institutions Holding OGN

# of Institutions

790

Shares Held

197M

Call Options Held

2.5M

Put Options Held

2.94M

Vanguard Group Inc Valley Forge, PA

35.9M
Shares

$271 Million
0.01% of portfolio
Black Rock Inc. New York, NY

32.6M
Shares

$245 Million
0.02% of portfolio
Massachusetts Financial Services CO Boston, MA

9.5M
Shares

$71.6 Million
0.03% of portfolio
State Street Corp Boston, MA

9.34M
Shares

$70.3 Million
0.0% of portfolio
Lsv Asset Management Chicago, IL

7.83M
Shares

$59 Million
0.18% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.92B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.

Account